Option Care Health Management
Management criteria checks 4/4
Option Care Health's CEO is John Rademacher, appointed in Aug 2017, has a tenure of 8.08 years. total yearly compensation is $8.22M, comprised of 12.2% salary and 87.8% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth $9.00M. The average tenure of the management team and the board of directors is 3 years and 6.7 years respectively.
Key information
John Rademacher
Chief executive officer
US$8.2m
Total compensation
| CEO salary percentage | 12.16% |
| CEO tenure | 8.1yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Why Option Care Health, Inc. (NASDAQ:OPCH) Could Be Worth Watching
Sep 09
Option Care Health: Continued Value Erosion At Current Rate Of Growth
Aug 04An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 43% Undervalued
Jul 25We Think The Compensation For Option Care Health, Inc.'s (NASDAQ:OPCH) CEO Looks About Right
May 08Option Care Health (NASDAQ:OPCH) Seems To Use Debt Quite Sensibly
Apr 19Why Investors Shouldn't Be Surprised By Option Care Health, Inc.'s (NASDAQ:OPCH) P/E
Mar 18Should You Investigate Option Care Health, Inc. (NASDAQ:OPCH) At US$32.09?
Feb 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 31% Undervaluation?
Jan 23Option Care Health, Inc.'s (NASDAQ:OPCH) Business Is Trailing The Market But Its Shares Aren't
Dec 13Is Option Care Health (NASDAQ:OPCH) Using Too Much Debt?
Nov 28Results: Option Care Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Oct 17There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Aug 30
Orphan Therapies And Strategic Resilience Propel Company's Year-Over-Year Growth
Diversification into new therapies and engagement with the investment community signal growth and proactive market capture, enhancing future revenue.Option Care Health: Revenue Lines Not Pulling Economic Weight (Rating Downgrade)
Aug 16We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Aug 15What Does Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Indicate?
Jul 15Option Care Health: A Deep Dive Into Its Market Dominance
May 31Option Care Health, Inc.'s (NASDAQ:OPCH) Shareholders Might Be Looking For Exit
May 23We Ran A Stock Scan For Earnings Growth And Option Care Health (NASDAQ:OPCH) Passed With Ease
May 10Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Feb 12Option Care Health (NASDAQ:OPCH) Has A Pretty Healthy Balance Sheet
Jan 02There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Dec 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 27% Undervaluation?
Dec 06With EPS Growth And More, Option Care Health (NASDAQ:OPCH) Makes An Interesting Case
Nov 08Is It Too Late To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Oct 26Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Sep 13Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 24% Discount?
Aug 30Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Aug 10Is Option Care Health, Inc. (NASDAQ:OPCH) Potentially Undervalued?
Jul 27Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Jun 09An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 37% Undervalued
May 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | US$211m |
| Mar 31 2025 | n/a | n/a | US$214m |
| Dec 31 2024 | US$8m | US$1m | US$212m |
| Sep 30 2024 | n/a | n/a | US$209m |
| Jun 30 2024 | n/a | n/a | US$211m |
| Mar 31 2024 | n/a | n/a | US$273m |
| Dec 31 2023 | US$17m | US$1m | US$267m |
| Sep 30 2023 | n/a | n/a | US$257m |
| Jun 30 2023 | n/a | n/a | US$240m |
| Mar 31 2023 | n/a | n/a | US$159m |
| Dec 31 2022 | US$7m | US$954k | US$151m |
| Sep 30 2022 | n/a | n/a | US$178m |
| Jun 30 2022 | n/a | n/a | US$175m |
| Mar 31 2022 | n/a | n/a | US$173m |
| Dec 31 2021 | US$8m | US$669k | US$140m |
| Sep 30 2021 | n/a | n/a | US$82m |
| Jun 30 2021 | n/a | n/a | US$48m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$1m | US$500k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$42m |
| Jun 30 2020 | n/a | n/a | -US$86m |
| Mar 31 2020 | n/a | n/a | -US$92m |
| Dec 31 2019 | US$856k | US$487k | -US$76m |
Compensation vs Market: John's total compensation ($USD8.22M) is about average for companies of similar size in the US market ($USD7.13M).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Rademacher (58 yo)
Mr. John C. Rademacher is the President of Option Care Health, Inc. (formerly known as Option Care Enterprises Inc.) and has serves as a Director since 2019. Mr. Rademacher is the Chief Executive Officer o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.1yrs | US$8.22m | 0.20% $ 9.0m | |
| Executive VP & CFO | 10.1yrs | US$4.12m | 0.070% $ 3.2m | |
| Chief Operating Officer | 2.7yrs | US$3.42m | 0.040% $ 1.8m | |
| General Counsel & Corporate Secretary | 3.4yrs | US$1.91m | 0.014% $ 629.9k | |
| Chief Growth Officer | 3.3yrs | US$1.73m | 0.0074% $ 341.8k | |
| Senior VP | 1.1yrs | no data | 0.0055% $ 252.7k | |
| Chief Information Officer | no data | no data | no data | |
| Senior VP & Chief Compliance Officer | less than a year | no data | no data | |
| Chief Human Resources & Chief Diversity Officer | 3.5yrs | US$2.08m | 0.00068% $ 31.2k | |
| Senior Vice President of Operations | no data | no data | no data | |
| Chief Medical Officer | 1.7yrs | no data | 0.0012% $ 53.8k | |
| Senior VP & Chief Information Security Officer | 1.7yrs | no data | no data |
Experienced Management: OPCH's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 6.7yrs | US$8.22m | 0.20% $ 9.0m | |
| Independent Director | 6.7yrs | US$267.50k | 0.030% $ 1.4m | |
| Independent Director | 1.3yrs | US$272.50k | 0.0011% $ 50.1k | |
| Independent Non Executive Chairman of the Board | 6.7yrs | US$416.00k | 0.21% $ 9.8m | |
| Independent Director | 10.7yrs | US$267.50k | 0.072% $ 3.3m | |
| Independent Director | 6.7yrs | US$282.50k | 0.018% $ 827.0k | |
| Independent Director | 10.7yrs | US$295.00k | 0.026% $ 1.2m | |
| Independent Director | 3.3yrs | US$278.50k | 0.0051% $ 232.9k | |
| Independent Director | 1.7yrs | US$370.23k | 0.0011% $ 49.2k | |
| Independent Director | 1.7yrs | US$377.94k | 0.0043% $ 195.7k | |
| Independent Director | 3.3yrs | US$292.50k | 0.0032% $ 148.4k |
Experienced Board: OPCH's board of directors are considered experienced (6.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/21 16:31 |
| End of Day Share Price | 2025/09/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Option Care Health, Inc. is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Richard Close | Canaccord Genuity |